Progressive stent technologies: new approaches for the treatment of cardiovascular diseases.

Abstract:

:The CYPHER (Cordis, Johnson & Johnson) sirolimus-eluting stent and the TAXU (Boston Scientific) paclitaxel-eluting stent have been extensively evaluated and have been proven to be significant novel tools for the treatment of coronary artery disease. Several sirolimus derivatives have already emerged, receiving CE Mark approval. However, in the future, it is likely that drugs presently under investigation will address additional mechanisms associated with neointimal formation, either as single agents or in combination with antiproliferative compounds. Concurrently, alterations on stent platform design (helicoidal, open-closed cell), coatings (biodegradable, bioabsorbable, nanoporous) and polymers are being explored.

journal_name

Expert Opin Drug Deliv

authors

Vaina S,Serruys PW

doi

10.1517/17425247.3.6.783

subject

Has Abstract

pub_date

2006-11-01 00:00:00

pages

783-97

issue

6

eissn

1742-5247

issn

1744-7593

journal_volume

3

pub_type

杂志文章,评审
  • Designing oral vaccines targeting intestinal dendritic cells.

    abstract:INTRODUCTION:Most pathogens colonize and invade the host at mucosal surfaces, such as the lung and the intestine. To combat intestinal pathogens the induction of local adaptive immune responses is required, which is mainly achieved through oral vaccination. However, most vaccines are ineffective when given orally owing...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2011.561312

    authors: Devriendt B,De Geest BG,Cox E

    更新日期:2011-04-01 00:00:00

  • Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.

    abstract:INTRODUCTION:Many drug candidates with high therapeutic efficacy have low water solubility, which limits the administration and transport across physiological barriers, for example, the tumor tissue barrier. Therefore, strategies are needed to permeabilize the physiological barriers safely so that hydrophobic drugs may...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.1021681

    authors: Wang G,Wang J,Wu W,Tony To SS,Zhao H,Wang J

    更新日期:2015-01-01 00:00:00

  • Strategies for triggered drug release from tumor targeted liposomes.

    abstract:INTRODUCTION:Long circulating liposomal drug carriers are widely used in experimental cancer therapy because they avoid excretion and benefit from the enhanced permeability and retention-effect to accumulate at the tumor site while simultaneously limiting systemic exposure to the cytotoxic drug due to their high stabil...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.805742

    authors: Oude Blenke E,Mastrobattista E,Schiffelers RM

    更新日期:2013-10-01 00:00:00

  • Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB.

    abstract:INTRODUCTION:The emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) is a major health issue and continues to be a global health concern. Despite significant advancements in treatment modalities, ~1.6 million deaths worldwide occur due to TB infection. This is bec...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2019.1609937

    authors: Sankhe K,Khan T,Bhavsar C,Momin M,Omri A

    更新日期:2019-05-01 00:00:00

  • Nanostructured hyaluronic acid-based materials for active delivery to cancer.

    abstract:IMPORTANCE OF THE FIELD:Active targeting of bioactive molecules by physicochemical association with hyaluronic acid (HA) is an attractive approach in current nanomedicine because HA is biocompatible, non-toxic and non-inflammatory. AREAS COVERED IN THIS REVIEW:This review focuses on synthesis, physicochemical characte...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425241003730399

    authors: Ossipov DA

    更新日期:2010-06-01 00:00:00

  • One-step solid-oil-water emulsion for sustained bioactive ranibizumab release.

    abstract:BACKGROUND:The advent of therapeutic proteins highlights the need for delivery systems that protect and extend the duration of its action. Ranibizumab-VEGF is one such drug used for treating wet AMD. This paper describes a facile method to sustain bioactive ranibizumab release from PLGA-based particles. METHODS:Two em...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2018.1538209

    authors: Chua HY,Lui YS,Bhuthalingam R,Agrawal R,Wong T,Preiser PR,Venkatraman S

    更新日期:2018-12-01 00:00:00

  • Starch microparticles as vaccine adjuvant.

    abstract::The demand for new vaccine adjuvants is well documented. New purified antigens from parasites, bacterial or viral pathogens, as well as recombinant subunit antigens and synthetic peptides, are often inherently weak immunogens; therefore, they need some kind of adjuvant to help initiate an immune response. In addition,...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2.5.807

    authors: Rydell N,Stertman L,Sjöholm I

    更新日期:2005-09-01 00:00:00

  • Pickering emulsions: challenges and opportunities in topical delivery.

    abstract:INTRODUCTION:Topical drug delivery is a challenging area with many advantages such as avoidance of first passage effect, stabilization of blood concentrations and attainment of local therapeutic effect with fewer side effects. Despite all these advantages, topical drug delivery remains limited to few molecules, since s...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1182489

    authors: Marto J,Ascenso A,Simoes S,Almeida AJ,Ribeiro HM

    更新日期:2016-08-01 00:00:00

  • Current status of non-viral gene therapy for CNS disorders.

    abstract:INTRODUCTION:Viral and non-viral vectors have been used as methods of delivery in gene therapy for many CNS diseases. Currently, viral vectors such as adeno-associated viruses (AAV), retroviruses, lentiviruses, adenoviruses and herpes simplex viruses (HHV) are being used as successful vectors in gene therapy at clinica...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1188802

    authors: Jayant RD,Sosa D,Kaushik A,Atluri V,Vashist A,Tomitaka A,Nair M

    更新日期:2016-10-01 00:00:00

  • Cancer stem cell-targeted therapeutics and delivery strategies.

    abstract:INTRODUCTION:Cancer initiating or stem cells (CSCs) are a small population of cells in the tumor mass, which have been reported to be present in different types of cancers. CSCs usually reside within the tumor and are responsible for reoccurrence of cancer. The imprecise, inaccessible nature and increased efflux of con...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2017.1263615

    authors: Ahmad G,Amiji MM

    更新日期:2017-08-01 00:00:00

  • The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems.

    abstract:INTRODUCTION:Nanoparticles are anticipated to overcome persistent challenges in efficient drug delivery, but the limitations associated with conventional methods of preparation are resulting in slow translation from research to clinical applications. Due to their enormous potential, microfluidic technologies have emerg...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2018.1446936

    authors: Martins JP,Torrieri G,Santos HA

    更新日期:2018-05-01 00:00:00

  • Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics.

    abstract:INTRODUCTION:Harnessing RNA interference as a therapeutic approach has the potential to significantly expand the druggable target space, offering new hope for treatment of diseases that cannot be addressed with existing classes of drugs. A number of siRNA therapeutics have already progressed into preclinical and clinic...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.642363

    authors: Gindy ME,Leone AM,Cunningham JJ

    更新日期:2012-02-01 00:00:00

  • Innovative therapeutics: from molecules to medicines. 27 June-7 July 2004, Parma, Italy.

    abstract::The Socrates Intensive Programme offers annual courses focusing on the specific aspects of innovative therapeutics. The 2004 meeting was coordinated by the University of Parma and covered various subjects in the field of advanced drug delivery and pharmaceutical technology, including sessions on biopharmaceutics, phar...

    journal_title:Expert opinion on drug delivery

    pub_type:

    doi:10.1517/17425247.1.1.185

    authors: Jiskoot W,Santi P

    更新日期:2004-11-01 00:00:00

  • An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part I.

    abstract:INTRODUCTION:Currently, hot melt extrusion (HME) is a promising technology in the pharmaceutical industry, as evidenced by its application to manufacture various FDA-approved commercial products in the market. HME is extensively researched for enhancing the solubility and bioavailability of poor water-soluble drugs, ta...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2019.1609448

    authors: Kallakunta VR,Sarabu S,Bandari S,Tiwari R,Patil H,Repka MA

    更新日期:2019-05-01 00:00:00

  • Extractables and leachables considerations for prefilled syringes.

    abstract:INTRODUCTION:Use of pre-filled syringes as both a packaging and delivery system for pharmaceutical drug products is accelerating. Pre-filled syringes must meet the quality and suitability for use requirements for both systems, including compatibility with the drug product. Relevant incompatibilities between pre-filled ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.928281

    authors: Jenke DR

    更新日期:2014-10-01 00:00:00

  • Novel hydrofluoroalkane suspension formulations for respiratory drug delivery.

    abstract::Due to the poor solvent properties of hydrofluoroalkanes, suspension is often the only formulation option for respiratory drug delivery. Research in this area has focussed mainly on two main themes over the past 5 years: new design of stabilisers and particle engineering. Among the most important advances, the introdu...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2.4.625

    authors: Rogueda P

    更新日期:2005-07-01 00:00:00

  • Drug delivery using multifunctional dendrimers and hyperbranched polymers.

    abstract:IMPORTANCE OF THE FIELD:The review presents the design strategy and synthesis of multifunctional dendrimers and hyperbranched polymers with the objective to develop effective drug delivery systems. AREAS COVERED IN THIS REVIEW:Well-characterized, commercially available dendritic polymers were subjected to functionaliz...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2010.534981

    authors: Paleos CM,Tsiourvas D,Sideratou Z,Tziveleka LA

    更新日期:2010-12-01 00:00:00

  • Hydrophobic polymers for orodispersible films: a quality by design approach.

    abstract:OBJECTIVES:To develop orodispersible films (ODF) based on hydrophobic polymers with higher stability to ordinary environmental humidity conditions without compromising their fast disintegration time. METHODS:A quality by design approach was applied to screen three different formulations each one based on a different h...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2016.1218458

    authors: Borges AF,Silva BM,Silva C,Coelho JF,Simões S

    更新日期:2016-10-01 00:00:00

  • Pulmonary cell culture models to study the safety and efficacy of innovative aerosol medicines.

    abstract:BACKGROUND:Pulmonary cell culture models for the development of new aerosol medicines are attracting increasing interest. Ease of handling, ethical acceptance and high explanatory power are the main advantages of cell culture systems in pulmonary drug research. OBJECTIVE:Pulmonary cell culture models are described and...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.6.641

    authors: Bur M,Lehr CM

    更新日期:2008-06-01 00:00:00

  • Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations.

    abstract:INTRODUCTION:Transdermal drug delivery has several known advantages over the oral route and hypodermic injections. The number of drugs that can be taken up transdermally is, however, limited owing to the innate barrier function of the skin. New transdermal drug candidates need to be tested extensively before being used...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2011.568937

    authors: Van Gele M,Geusens B,Brochez L,Speeckaert R,Lambert J

    更新日期:2011-06-01 00:00:00

  • RNA interference technology for anti-VEGF treatment.

    abstract:INTRODUCTION:Overexpression of VEGF has been identified to be associated with many pathologic processes such as tumors and retinopathy. Inhibiting uncontrolled growth of VEGF is a promising strategy to treat these diseases. Currently small molecule inhibitors and monoclonal antibodies are the primary treatment. However...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.926886

    authors: Chen S,Feng J,Ma L,Liu Z,Yuan W

    更新日期:2014-09-01 00:00:00

  • Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors.

    abstract:INTRODUCTION:Transportation of the nutrients and other substances from the blood to the brain is selectively controlled by the brain capillary endothelial cells that form a restrictive barrier, so-called blood-brain barrier (BBB). Currently, there is no unimpeachable approach to overcome the BBB obstructiveness because...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2019.1614911

    authors: Jafari B,Pourseif MM,Barar J,Rafi MA,Omidi Y

    更新日期:2019-06-01 00:00:00

  • Polymer-drug conjugates: recent progress on administration routes.

    abstract:INTRODUCTION:Polymer-drug conjugates are an important part of polymer therapeutics. Recently, they have been used as an appealing platform for drug delivery. As a delivery vector, the route of administration performs a serious impact on the accessibility of drug molecules to their respective target site and therapeutic...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.912779

    authors: Pang X,Yang X,Zhai G

    更新日期:2014-07-01 00:00:00

  • Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.

    abstract::The introduction of insulin pens has helped improve adherence in Type 1 or 2 diabetes, and reduce inaccurate dosing, fear of injection, and social embarrassment associated with vial and syringe. This report presents the published evidence base for the accuracy, patient preference and economic evaluation of one prefill...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.8.915

    authors: Pfützner A,Asakura T,Sommavilla B,Lee W

    更新日期:2008-08-01 00:00:00

  • Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.

    abstract:INTRODUCTION:Radioimmunotherapy (RIT) with monoclonal antibodies and their fragments labelled with radionuclides emitting α -particles, β-particles or Auger electrons have been used for many years in the development of anticancer strategies. While RIT has resulted in approved radiopharmaceuticals for the treatment of h...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2018.1378180

    authors: Martins CD,Kramer-Marek G,Oyen WJG

    更新日期:2018-02-01 00:00:00

  • Nanocarrier-based topical drug delivery for the treatment of skin diseases.

    abstract:INTRODUCTION:Skin disorders will continue to cause complications in patients. At present, there is an expansion of research into dermatologic treatment due to a critical need for new treatment options to treat skin diseases. AREAS COVERED:The skin itself provides a natural barrier against particle penetration for topi...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.686490

    authors: Gupta M,Agrawal U,Vyas SP

    更新日期:2012-07-01 00:00:00

  • Controlled inhalation of aerosolised therapeutics.

    abstract::With the advent of new, and often expensive, therapeutics designed for aerosol delivery to the lung, there is a need to improve the targeting and efficiency of their delivery. By controlling breathing patterns associated with inhaled aerosols, it has been shown that deposition in the lung can be both maximised and tar...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1517/17425247.2.4.763

    authors: Bennett WD

    更新日期:2005-07-01 00:00:00

  • Liposome technology for cardiovascular disease treatment and diagnosis.

    abstract:INTRODUCTION:Over the past several decades, liposomes have been used in a variety of applications, from delivery vehicles to cell membrane models. In terms of pharmaceutical use, they can offer control over the release of active agents encapsulated into their lipid bilayer or aqueous core, while providing protection fr...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.647908

    authors: Bowey K,Tanguay JF,Tabrizian M

    更新日期:2012-02-01 00:00:00

  • Clinical advances of nanocarrier-based cancer therapy and diagnostics.

    abstract:INTRODUCTION:Cancer is a leading cause of death worldwide and efficient new strategies are urgently needed to combat its high mortality and morbidity statistics. Fortunately, over the years, nanotechnology has evolved as a frontrunner in the areas of imaging, diagnostics and therapy, giving the possibility of monitorin...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1205585

    authors: Luque-Michel E,Imbuluzqueta E,Sebastián V,Blanco-Prieto MJ

    更新日期:2017-01-01 00:00:00

  • Role of calcium in gene delivery.

    abstract::The treatment of genetic diseases using therapeutic gene transfer is considered to be a significant development. This development has brought with it certain limitations, and the process of overcoming these barriers has seen a drastic change in gene delivery. Many metal ions such as Mg2+, Mn2+, Ba2+ and, most importan...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1517/17425247.3.2.235

    authors: Kulkarni VI,Shenoy VS,Dodiya SS,Rajyaguru TH,Murthy RR

    更新日期:2006-03-01 00:00:00